Conversely, pharmacological blockade of TLR4 activity tended to decrease the effect of NASH fEVs on IL‐6, IL‐8, CCL2 and CXCL1 production in endothelial cells. This evidence concerns the gene CXCL1 and metabolic dysfunction-associated steatohepatitis.